Minimally invasive techniques to treat lower extremity vascular disease, abdominal aortic aneurysm, and carotid artery stenosis continue to evolve as endovascular technologies improve. Learn about outcomes data for these techniques, and when they are—or are not—more appropriate than open surgery.Read More
Venous thromboembolism (VTE), defined as deep venous thrombosis (DVT), pulmonary embolism (PE), or both, is one of the leading causes of preventable in-hospital mortality. Learn how hospitals can prevent VTEs by implementing evidence-based guidelines for risk assessment and prophylaxis.Read More
The Centers for Disease Control and Prevention (CDC) estimates that each year, approximately 300,000-600,000 patients in the US are affected by venous thromboembolism (VTE). Lower-extremity deep venous thrombosis (DVT) is the most common type of VTE, with the majority of cases occurring in either the proximal lower extremity (36%) or the calf and proximal lower extremity (37%)…Read More
Varicose veins are a common condition that, in Western countries, can affect up to 73% of adult women and up to 56% of adult men (1). Varicose veins are often caused by venous reflux, a disorder resulting from damaged or failed valves—usually in the superficial veins of the leg.Read More
The Complex Aortic Surgery Program is designed to treat complex aortic aneurysm involving the thoracic and the abdominal aorta, as well as the visceral vessels that feed blood to the intestines and kidneys…Read More
UWHealth ImageShare is a complimentary service designed to expedite image sharing between UW Health and partnering organizations. A site-to-site VPN (virtual private network) is established that will allow for fast and secure two-way exchange of DICOM images.Read More
A list of active vascular surgery trials currently recruiting at the UW Department of Surgery:
The purpose of this Phase 2 study is to optimize Plasmin delivery by comparing four different delivery regimens in patients with acute peripheral arterial occlusion. The study will also compare Plasmin to placebo and to plasminogen activators.